GW PHARMACEUTICALS PLC Stock-Based Compensation
GW PHARMACEUTICALS PLC reported Stock-Based Compensation of $17.79 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2021-05-03
- GW PHARMACEUTICALS PLC share-based payment arrangement, noncash expense for the quarter ending 2021-03-31 was $17.79M, a 56.57% increase year-over-year.
- GW PHARMACEUTICALS PLC share-based payment arrangement, noncash expense for the quarter ending 2020-12-31 was $17.91M, a 44.49% increase year-over-year.
- GW PHARMACEUTICALS PLC share-based payment arrangement, noncash expense for the quarter ending 2020-09-30 was $15.77M, a 28.17% increase year-over-year.
- GW PHARMACEUTICALS PLC share-based payment arrangement, noncash expense for the quarter ending 2020-06-30 was $13.32M, a 9.26% increase year-over-year.
- GW PHARMACEUTICALS PLC share-based payment arrangement, noncash expense for fiscal 2020 was $58.36M, a 21.51% increase from fiscal 2019.
- GW PHARMACEUTICALS PLC share-based payment arrangement, noncash expense for fiscal 2019 was $48.03M.
- GW PHARMACEUTICALS PLC share-based payment arrangement, noncash expense for fiscal 2018 was $31.63M, a 104.32% increase from fiscal 2017.
- GW PHARMACEUTICALS PLC share-based payment arrangement, noncash expense for fiscal 2017 was $15.48M, a 22.26% increase from fiscal 2016.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2021-03-31 | $17.79M 10-Q · filed 2021-05-03 | $35.70M derived: sum of 2 quarters · filed 2021-05-03 | $51.47M derived: sum of 3 quarters · filed 2021-05-03 | $64.79M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | $17.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $33.68M derived: sum of 2 quarters · filed 2021-02-26 | $47.00M derived: sum of 3 quarters · filed 2021-02-26 | $58.36M 10-K · filed 2021-02-26 |
| 2020-09-30 | $15.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $29.09M derived: sum of 2 quarters · filed 2020-11-05 | $40.45M 10-Q · filed 2020-11-05 | $52.84M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | $13.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $24.68M 10-Q · filed 2020-08-07 | $37.07M derived: sum of 3 quarters · filed 2021-05-03 | $49.38M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | $11.36M 10-Q · filed 2021-05-03 | $23.76M derived: sum of 2 quarters · filed 2021-05-03 | $36.06M derived: sum of 3 quarters · filed 2021-05-03 | $48.25M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $12.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $24.70M derived: sum of 2 quarters · filed 2021-02-26 | $36.89M derived: sum of 3 quarters · filed 2021-02-26 | $48.03M 10-K · filed 2021-02-26 |
| 2019-09-30 | $12.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $24.49M derived: sum of 2 quarters · filed 2020-11-05 | $35.63M 10-Q · filed 2020-11-05 | $45.32M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $12.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $23.33M 10-Q · filed 2020-08-07 | $33.01M derived: sum of 3 quarters · filed 2021-02-26 | $42.62M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $11.14M 10-Q · filed 2020-05-11 | $20.82M derived: sum of 2 quarters · filed 2021-02-26 | $30.43M derived: sum of 3 quarters · filed 2021-02-26 | $40.00M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $9.68M 10-K · filed 2021-02-26 | $19.29M derived: sum of 2 quarters · filed 2021-02-26 | $28.86M derived: sum of 3 quarters · filed 2021-02-26 | $35.72M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | $9.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $19.18M derived: sum of 2 quarters · filed 2019-11-06 | $26.04M 10-Q · filed 2019-11-06 | $31.63M 10-K · filed 2021-02-26 |
| 2018-06-30 | $9.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $16.43M 10-Q · filed 2019-08-07 | $22.02M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-03-31 | $6.86M 10-Q · filed 2019-05-08 | $12.45M derived: sum of 2 quarters · filed 2021-02-26 | ||
| 2017-12-31 | $5.59M 10-K · filed 2021-02-26 | |||
| 2017-09-30 | $15.48M 10-K · filed 2020-02-27 | |||
| 2016-09-30 | $12.66M 10-KT · filed 2019-02-28 |